President, CEO and Director
Nabil Shabshab has served as our Chief Executive Officer, President and a member of our Board since February 2021. Prior to joining Inogen, Mr. Shabshab served as Worldwide President of Diabetes Care and Digital Health at Becton Dickinson and Company, a leading medical technology company, from August 2017 to February 2021. Prior to that, since August 2011, Mr. Shabshab served as Becton Dickinson’s Chief Marketing Officer and Executive Vice President of Strategic Planning. Prior to Becton Dickinson, Mr. Shabshab served as EVP, Global Portfolio, Chief Marketing Officer and Head of RD&E of Diversey, Inc., a cleaning and sanitation solutions company from 2006 to 2010. In his previous roles Mr. Shabshab served as Principal with The Zyman Group, as Vice President, Client Solutions and Consulting with Symphony IRI, and in various sales and marketing roles in pharmaceutical and consumer goods companies including Warner Lambert / Pfizer, the Coca-Cola Company, and Fronterra. Mr. Shabshab holds an MBA from Northwestern University Kellogg School of Management and a B.S. in Computer Sciences from American Lebanese University.
Chief Commercial Officer
George Parr joined Inogen as the Executive Vice President, Chief Commercial Officer in April of 2021. Prior to joining Inogen, Mr. Parr served as Executive Vice President & Chief Marketing Officer at Becton Dickinson and Company, a leading medical technology company, from November 2017 through January 2020. Previously, from 2014 to 2017, Mr. Parr served as Senior Vice President & Chief Marketing Officer at SIRVA Worldwide Relocation & Moving, a moving industry company. Prior to that, from 2006 to 2013, Mr. Parr served at Diversey, Inc., a cleaning and hygiene solutions company, as Senior Vice President & Chief Marketing Officer from 2010 to 2013 and Worldwide General Manager, Kitchen Hygiene & Fabric Care from 2006 to 2010. Prior to that, Mr. Parr served in various managing roles in consumer goods companies. Mr. Parr holds an MBA from DePaul University and a B.S. in Accounting from LaSalle University.
Dr. Stanislav Glezer
Chief Technology Officer
Dr. Stanislav Glezer has served as our Executive Vice President, Chief Technology Officer since October 2021 after serving as the Executive Vice President, Chief Medical Officer from June 2021 to October 2021. Prior to joining Inogen, Dr. Glezer was with Becton, Dickinson and Company, a global medical technology company where he served as the Worldwide Vice President of Medical Affairs for Diabetes Care since September 2018. Prior to joining Becton Dickinson, Dr. Glezer served as the Chief Medical Officer at Adocia S.A. a biotechnology company, from 2017 to 2018. From 2016 to 2017, Dr. Glezer served as Vice President of Global Medical Affairs at Novo Nordisk, Inc., a healthcare company. Earlier, Dr. Glezer served in a number of roles of progressively increasing seniority, including, Global Project Head for the largest late-stage pipeline asset, Vice President of Evidence and Value & Access, Vice President of Medical Affairs, and Senior Director of Medical Strategy & Operations, for Sanofi S.A., a multinational pharmaceutical company, from 2001 to 2015. Dr. Glezer holds a Doctor of Medicine from Moscow State University of Medicine and Dentistry and a MBA from California Coast University.
Executive Vice President and Chief Financial Officer
Kristin Caltrider joined Inogen on March 21, 2022 as EVP and Chief Financial Officer. She brings more than 30 years of progressive finance experience and has assumed different roles of increasing scope and responsibilities at Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. Ms Caltrider served as Quidel’s Vice President of Finance since June 2014 where she oversaw global Finance and Accounting functions, which included all aspects of transactional and technical accounting, tax and treasury, financial planning and analysis, cash management and forecasting, as well as finance-related M&A activities. Prior to joining Quidel, Ms. Caltrider spent almost four years at Life Technologies (Invitrogen Corporation), where she held a number of positions and prior to that she was the North America Controller for Pulse Electronics. Ms. Caltrider graduated from California Lutheran University with a bachelor’s degree in Business Administration, and also holds an MBA from the University of San Diego.
Executive Vice President, Operations
Bart Sanford has served as our Executive Vice President, Operations since September 2018. From April 2017 to September 2018, Mr. Sanford was Senior Vice President, Operations, at Cepheid Inc., a molecular diagnostics company. From October 2010 to March 2017, Mr. Sanford was Vice President, Global Operations, at Molecular Devices, LLC, a life sciences company. From January 2009 to September 2010, Mr. Sanford was a Corporate Director at Danaher Corporation, a medical device company. From March 2000 to December 2008, Mr. Sanford held various positions at Fluke Corporation, an industrial test product company, including plant manager, manufacturing manager and materials manager. Mr. Sanford received an MBA from Central Michigan University and a Bachelor of Arts degree in Logistics, Materials and Supply Chain Management from Michigan State University.
Executive Vice President, General Counsel
Jason Somer joined Inogen as the Executive Vice President, General Counsel in July 2021. Prior to joining Inogen, Mr. Somer served as head Legal Counsel at Invoca, Inc., a SaaS analytics company. Prior to his time at Invoca, Mr. Somer served as Associate General Counsel at Sunniva, Inc., and as General Counsel and Corporate Secretary for Innova Gaming Group, a gaming company. Prior to joining Innova, Mr. Somer served as the Senior Vice President of Business Development and General Counsel at Sunora Energy Solutions, a solar energy development company. Mr. Somer also previously served as the Vice President of Special Projects and the Senior Global Counsel at Suntech Power, a Shanghai-based solar energy technology company. Prior to joining Suntech Power, Mr. Somer served as Director of Legal Affairs & Business Development at Ironport Systems, Inc. and as Associate General Counsel and a Business Development Director at Neoforma, Inc. Mr. Somer joined Neoforma from Morrison & Foerster where he was a corporate/securities associate based in New York. Mr. Somer holds a L.L.M. from Boston University, a L.L.B. from the University of British Columbia School of Law, and a B.Sc. from the University of Western Ontario in Biology/Pharmacology.
Jennifer Yi Boyer
Executive Vice President, Chief Human Resources Officer
Jennifer Yi Boyer is Inogen’s EVP, Chief Human Resources Officer. Jennifer is playing a critical role in improving Inogen’s organizational effectiveness to elevate inter- and cross-departmental efficiency and productivity, as well as modernizing talent acquisition, retention and development across the board. Her efforts are focused on enabling our strategic imperatives in support of our growth goals and our envisioned culture.
Jennifer brings to the company 25 years of strategic and transformational HR leadership experience with deep expertise in the areas of Talent Acquisition, Talent Development, Organization Effectiveness, Transformational Leadership, DEI (Diversity, Equity & Inclusion), and workforce planning. Her work has been recognized by the Society for HR Management for innovation in HR and she was recently recognized as one of the top 100 DEI Leaders by Mogul
Jennifer obtained her undergraduate degree from Cornell University, her Masters’ degree from Seton Hall University and completed an Executive Leadership Certificate at the JFK School of Government at Harvard University.
Senior Vice President of Investor Relations and Strategic Planning
Agnes is Inogen’s Senior Vice President of Investor Relations and Strategic Planning. She brings more than 25 years of investor relations, operational and strategic finance, and communications across small, medium and large capitalization companies.
Previously, she served as Vice President of Investor Relations of Butterfly Network, Inc. While at Butterfly, she created an investor relations program to promote the company to analysts and investors, and collaboratively led investor marketing to reflect an evolution of the company’s vision and strategy. Prior to Butterfly, Agnes led proactive investor relations programs at Fluidigm Corporation, ResMed Inc., a NYSE and ASX dual-listed company, and Life Technologies, which was acquired by Thermo Fisher Scientific in 2014. Before that role, Agnes spent almost a decade serving in increasingly senior finance leadership roles at Life Technologies, Applied Biosystems, and Celera Diagnostics. Earlier in her career, Agnes was an investment banker at Banc of America Securities and Salomon Smith Barney.
She earned an MBA in Finance and Marketing from the Kellogg School of Management at Northwestern University and a BA in Economics and International Affairs from Indiana University at Bloomington.